Graham Joseph Blaker

Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada.

Genosis Plc manufactures and develops medical devices. The company was founded in January 1998 by Paul Bateman and is headquartered in Esher, the United Kingdom.

Part of AIXTRON SE, Thomas Swan & Co. Ltd is a leading independent manufacturer of performance and fine chemicals. The company, founded in 1926 by Tommy Swan and based in Consett, UK, manufactures over 100 products, from kilogram to multi-tonne quantities, and offers an experienced and flexible custom manufacturing service. As an EPA authorized site, Thomas Swan has years of experience in the manufacture and formulation of agrochemicals and agrochemical intermediates. The British company produces over 100 high-quality products across three key divisions, which are used extensively in a wide range of anti-microbial, disinfectant, and detergent applications marketed outside of the European Union. Harry Macklyn Swan has been the CEO of the company since 2002.

IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany.